Note: When a project is scientific based, it is best to write the abstract in such a way the nonscientific type of person can understand what is being conveyed. This example is too technical for most ...
Successful abstracts exhibit what is generally accepted as good scientific ... If your undergraduate research is organic chemistry, for example, select Undergraduate Research Posters: Organic ...
The podcasting feature was launched in mid-September as part of NotebookLM, a year-old AI-powered research assistant.
For example, when looking at the painting on the right our brain can imagine the movements performed by Kandinsky in its creation. Brush-strokes are a major feature of abstract art. Unlike ...
Interfaces, however, support multiple inheritances where abstract classes don't. Implementation is done similarly in Java. For example, using the keyword implements will make a Java interface, while ...
The method comprises receiving, by a substance management system, a dosage instruction for administering a substance to an ...
At 7 p.m. Thursday, Sept. 19, 2024, people trickled into the Rubenstein Arts Center Film Theater for “Lodestar: Phil Solomon, ...
Researchers created 1.5 million AI-generated material narratives to address biases in materials science, enabling a more ...
Graphical Abstract The authors conducted a systematic literature screening ... underpowered studies, small sample size, and the lack of control for comorbidities, medications, severity of drug ...
Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its ...
Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced an upcoming poster presentation at the American College of Gastroenterology (ACG) Annual ...
Rapid oral presentation: Title: Petosemtamab (MCLA-158) monotherapy in previously treated (2L+) recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): Phase 2 trial Abstract #: ...